50 likes | 63 Views
The neuroregeneration therapy market has significant potential for addressing various neurological disorders and injuries, such as spinal cord injuries, stroke, Alzheimer's disease, Parkinson's disease, and peripheral neuropathy. These conditions often lead to irreversible nerve damage or loss, resulting in long-term disabilities or impairments. Neuroregeneration therapies offer hope for restoring or improving neural function, enhancing the quality of life for patients, and potentially reducing healthcare costs associated with long-term care and rehabilitation.<br><br>
E N D
Neuroregeneration Therapy Market Market Size (2022) US$ 11.67 Bn Market Size (2030) US$ 26.61 Bn CAGR (2023–2030) 12.5%
Segmentation (Scope) By Material Type: By Sales Channel: • Plastics • Metals • Ceramics • Composites • Others • Aerospace and defense, • Automotive, • Healthcare and medical, • Consumer products, • Industrial manufacturing, • Education and research, • Architecture and construction, Others By Form: By Technology: • Filament, • Powder, • Liquid, • Granules, • Others • Fused Deposition Modeling (FDM), • Selective Laser Sintering (SLS), • Stereolithography(SLA), • Binder Jetting, • Material Jetting, © Coherent Market Insights. All Rights Reserved
Major Drivers • Increasing Prevalence of Neurological Disorders • Technological Advancements • Growing Investment in Research and Development • Favorable Regulatory Environment © Coherent Market Insights. All Rights Reserved
Major Players Biogen Inc. Ceregene Inc. AstraZeneca PLC Abbott Laboratories Medtronic plc, Pfizer Inc. Novartis International AG, F. Hoffmann-La Roche Ltd.. Sanofi S.A Merck & Co., Inc. © Coherent Market Insights. All Rights Reserved